| 1741 |
|
The Biological and Biochemical Effects of CP-654577, a Selective erbB2 Kinase Inhibitor, on Human Breast Cancer Cells/
|
Barbacci, E. G
|
Williams and Wilkins
|
2003
|
|
|
|
| 1742 |
|
The Cardiac Homeobox Gene NKX2-5 Is Deregulated by Juxtaposition with BCL11B in Pediatric T-ALL Cell Lines via a Novel t(5; 14)(q35.1; q32.2)/
|
Nagel, S
|
Williams and Wilkins
|
2003
|
|
|
|
| 1743 |
|
The CC Chemokine MCP-1/CCL2 in Pancreatic Cancer Progression: Regulation of Expression and Potential Mechanisms of Antimalignant Activity/
|
Monti, P
|
Williams and Wilkins
|
2003
|
|
|
|
| 1744 |
|
The CCL6 Chemokine Is Differentially Regulated by c-Myc and L-Myc, and Promotes Tumorigenesis and Metastasis/
|
Yi, F
|
Williams and Wilkins
|
2003
|
|
|
|
| 1745 |
|
The Chemokine Receptor CXCR4 Is Required for Outgrowth of Colon Carcinoma Micrometastases/
|
Zeelenberg, I. S
|
Williams and Wilkins
|
2003
|
|
|
|
| 1746 |
|
The Circulating Dendritic Cell Compartment in Patients with Chronic Lymphocytic Leukemia Is Severely Defective and Unable to Stimulate an Effective T-Cell Response/
|
Orsini, E
|
Williams and Wilkins
|
2003
|
|
|
|
| 1747 |
|
The cis Decoy against the Estrogen Response Element Suppresses Breast Cancer Cells via Target Disrupting c-fos not Mitogen-activated Protein Kinase Activity/
|
Wang, L. H
|
Williams and Wilkins
|
2003
|
|
|
|
| 1748 |
|
The Contribution of Genetic and Epigenetic Mechanisms to Gene Silencing in Oligodendrogliomas/
|
Hong, C
|
Williams and Wilkins
|
2003
|
|
|
|
| 1749 |
|
The Cytoplasmic Domain Is Critical to the Tumor Suppressor Activity of TSLC1 in Non-Small Cell Lung Cancer/
|
Mao, X
|
Williams and Wilkins
|
2003
|
|
|
|
| 1750 |
|
The Cytotoxic T-Lymphocyte Response against a Poorly Immunogenic Mammary Adenocarcinoma Is Focused on a Single Immunodominant Class I Epitope Derived from the gp70 Env Product of an Endogenous Retrovirus/
|
Rosato, A
|
Williams and Wilkins
|
2003
|
|
|
|
| 1751 |
|
The Days and Nights of Cancer Cells/
|
Canaple, L
|
Williams and Wilkins
|
2003
|
|
|
|
| 1752 |
|
The Different Biological Effects of Telomestatin and TMPyP4 Can Be Attributed to Their Selectivity for Interaction with Intramolecular or Intermolecular G-Quadruplex Structures/
|
Kim, M.-Y
|
Williams and Wilkins
|
2003
|
|
|
|
| 1753 |
|
The Drg-1 Gene Suppresses Tumor Metastasis in Prostate Cancer/
|
Bandyopadhyay, S
|
Williams and Wilkins
|
2003
|
|
|
|
| 1754 |
|
The G~2-phase Decatenation Checkpoint Is Defective in Werner Syndrome Cells/
|
Franchitto, A
|
Williams and Wilkins
|
2003
|
|
|
|
| 1755 |
|
The Gatekeeper Effect of Epithelial-Mesenchymal Transition Regulates the Frequency of Breast Cancer Metastasis/
|
Xue, C
|
Williams and Wilkins
|
2003
|
|
|
|
| 1756 |
|
The Gene Expression Response of Breast Cancer to Growth Regulators: Patterns and Correlation with Tumor Expression Profiles/
|
Cunliffe, H. E
|
Williams and Wilkins
|
2003
|
|
|
|
| 1757 |
|
The Generation of a Conditional Reporter That Enables Bioluminescence Imaging of Cre/IoxP-Dependent Tumorigenesis in Mice/
|
Lyons, S. K
|
Williams and Wilkins
|
2003
|
|
|
|
| 1758 |
|
The HE4 (WFDC2) Protein Is a Biomarker for Ovarian Carcinoma/
|
Hellstrom, I
|
Williams and Wilkins
|
2003
|
|
|
|
| 1759 |
|
The Heat Shock Protein 90 Inhibitor Geldanamycin and the ErbB Inhibitor ZD1839 Promote Rapid PP1 Phosphatase-Dependent Inactivation of AKT in ErbB2 Overexpressing Breast Cancer Cells/
|
Xu, W
|
Williams and Wilkins
|
2003
|
|
|
|
| 1760 |
|
The Histone Deacetylase Inhibitor MS-275 Promotes Differentiation or Apoptosis in Human Leukemia Cells through a Process Regulated by Generation of Reactive Oxygen Species and Induction of p21^C^I^P^1^/^W^A^F^1/
|
Rosato, R. R
|
Williams and Wilkins
|
2003
|
|
|
|